1.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 60 to 80 Sponsor: Other Protocol IDs: PROLOG, NCT00675168
|
|
2.
|
Phase: Phase IV Type: Diagnostic Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: K36, NCT01469026
|
|
3.
|
Phase: Phase III Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CALGB-50303, ECOG-50303, NCI-05-C-0252, NCT00118209
|
|
4.
|
Phase: Phase III Type: Diagnostic Status: Active Age: 19 to 90 Sponsor: Other Protocol IDs: R05-0076, NCT00207298
|
|
5.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 15 to 70 Sponsor: Other Protocol IDs: CDR0000531125, EORTC-20051, GELA-H10, IIL-EORTC-20051, EUDRACT-2005-002765-37, EU-20657, NCT00433433
|
|
6.
|
Phase: Phase III Type: Diagnostic, Treatment Status: Active Age: 17 and under Sponsor: Other Protocol IDs: CDR0000531687, EURONET-PHL-C1, EU-20703, EUDRACT-2006-000995-33, CCLG-HD-2007-10, NCT00433459
|
|
7.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CRUK-2007-006064-30, 2007-006064-30, CRUK-07/146, NCT00678327
|
|
8.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: CDR0000633503, GOELAMS-LH2007, GOELAMS-ID-RCB#2007-A01079-44, INCA-RECF0754, AMGEN-GOELAMS-LH2007, NCT00920153
|
|
9.
|
Phase: Phase III Type: Treatment Status: Active Age: 16 to 75 Sponsor: Other Protocol IDs: CHNT-RAPID, RAPID, ISRCTN99811594, EU-20931, NCT00943423
|
|
10.
|
Phase: Phase III Type: Diagnostic, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: LNH 2009-1B, NCT01285765
|
|
11.
|
Phase: Phase III Type: Diagnostic, Treatment Status: Active Age: 61 to 80 Sponsor: Other Protocol IDs: DSHNHL 2009-1, NCT01478542
|
|
12.
|
Phase: Phase III Type: Diagnostic, Treatment Status: Approved-not yet active Age: 18 to 60 Sponsor: Other Protocol IDs: EORTC-20101-23101, 2011-005473-22, NCT01652261
|
|
13.
|
Phase: Phase II, Phase I Type: Diagnostic Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00600, U10CA080098, CDR0000521453, GOG-0233, ACRIN-6671, NCT00416455
|
|
14.
|
Phase: Phase II, Phase I Type: Diagnostic Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 080200, 08-C-0200, NCI-08-C-0200, NCI-P07341, 8333, NCT00775268
|
|
15.
|
Phase: Phase II, Phase I Type: Treatment Status: Approved-not yet active Age: 6 to 120 Sponsor: Other Protocol IDs: HITHD-01, NCT01005043
|
|
16.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000669535, CRUK-CR0720-11, CRUK-MK-0752, EUDRACT-2008-004829-42, CR0720-11, NCT01098344
|
|
17.
|
Phase: Phase II Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: I03017, NCT00199680
|
|
18.
|
Phase: Phase II Type: Diagnostic Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: TMH/205/2004/Cx_PET STUDY, NCT00193752
|
|
19.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic Status: Active Age: Not specified Sponsor: Other Protocol IDs: 04-0264-C, NCT00188253
|
|
20.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 717/05, NCT00254683
|
|
21.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2006LS016, UMN-0604M85308, UMN-2006LS016, NCT00379197
|
|
22.
|
Phase: Phase II Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 20328, E-20328, NCT00385164
|
|
23.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 070058, 07-C-0058, NCI-07-C-0058, NCI-P6840, 7358, NCT00436215
|
|
24.
|
Phase: Phase II Type: Treatment Status: Active Age: 21 and over Sponsor: Other Protocol IDs: 2006/098, NCT00503178
|
|
25.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UW-6143, UW IRB# 6143, 7958, NCT00559377
|